<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(2)</volume><submitter>Lim JY</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>B-type natriuretic peptide (BNP) is a biomarker predicting morbidity and mortality in patients with congestive heart failure. However, the usefulness of pre- or postoperative BNP levels in patients undergoing cardiac surgery remains uncertain. We sought to determine the association of pre- or postoperative BNP levels on mortality in patients undergoing cardiac surgery under cardiopulmonary bypass (CPB).&lt;h4>Methods&lt;/h4>This study retrospectively evaluated 1,642 patients undergoing cardiac surgery under CPB over 2 years. The primary outcomes were 30-day and overall mortality after cardiac surgery.&lt;h4>Results&lt;/h4>The 30-day mortality rate was 3.0% (n=49), and the overall mortality occurred in 118 patients during the mean follow-up period of 24.9±8.9 months. In multivariable</pubmed_abstract><journal>Journal of thoracic disease</journal><pagination>955-967</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7947500</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>B-type natriuretic peptide as a surrogate marker for survival in patients undergoing cardiac surgery.</pubmed_title><pmcid>PMC7947500</pmcid><pubmed_authors>Jung SH</pubmed_authors><pubmed_authors>Lim JY</pubmed_authors><pubmed_authors>Chung CH</pubmed_authors><pubmed_authors>Choo SJ</pubmed_authors><pubmed_authors>Kim JB</pubmed_authors><pubmed_authors>Lee JW</pubmed_authors></additional><is_claimable>false</is_claimable><name>B-type natriuretic peptide as a surrogate marker for survival in patients undergoing cardiac surgery.</name><description>&lt;h4>Background&lt;/h4>B-type natriuretic peptide (BNP) is a biomarker predicting morbidity and mortality in patients with congestive heart failure. However, the usefulness of pre- or postoperative BNP levels in patients undergoing cardiac surgery remains uncertain. We sought to determine the association of pre- or postoperative BNP levels on mortality in patients undergoing cardiac surgery under cardiopulmonary bypass (CPB).&lt;h4>Methods&lt;/h4>This study retrospectively evaluated 1,642 patients undergoing cardiac surgery under CPB over 2 years. The primary outcomes were 30-day and overall mortality after cardiac surgery.&lt;h4>Results&lt;/h4>The 30-day mortality rate was 3.0% (n=49), and the overall mortality occurred in 118 patients during the mean follow-up period of 24.9±8.9 months. In multivariable</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Feb</publication><modification>2025-04-05T10:36:08.127Z</modification><creation>2025-02-19T01:39:51.37Z</creation></dates><accession>S-EPMC7947500</accession><cross_references><pubmed>33717568</pubmed><doi>10.21037/jtd-20-2375</doi></cross_references></HashMap>